Interwest Venture Management Co is an investment fund managing more than $20.6 billion ran by Karen Wilson. There are currently 5 companies in Mrs. Wilson’s portfolio. The largest investments include Pmv Pharmaceuticals Inc and The Realreal, together worth $14.9 billion.
As of 13th October 2023, Interwest Venture Management Co’s top holding is 1,614,911 shares of Pmv Pharmaceuticals Inc currently worth over $9.92 billion and making up 48.1% of the portfolio value.
Relative to the number of outstanding shares of Pmv Pharmaceuticals Inc, Interwest Venture Management Co owns more than approximately 0.1% of the company.
In addition, the fund holds 2,354,080 shares of The Realreal worth $4.97 billion.
The third-largest holding is Sera Prognostics worth $4.49 billion and the next is Glaukos worth $1.23 billion, with 16,347 shares owned.
Currently, Interwest Venture Management Co's portfolio is worth at least $20.6 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Interwest Venture Management Co office and employees reside in Los Altos, California. According to the last 13-F report filed with the SEC, Karen Wilson serves as the CFO at Interwest Venture Management Co.
The two most similar investment funds to Interwest Venture Management Co are Cross Creek Advisors and Icahn Carl C. They manage $20.5 billion and $20.9 billion respectively.
Interwest Venture Management Co’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 54.2% of
the total portfolio value.
The fund focuses on investments in the United States as
60.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
20% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $874 million.
These positions were updated on October 20th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Pmv Pharmaceuticals Inc |
No change
1,614,911
|
$9,915,554,000 | 48.05% |
| The Realreal |
No change
2,354,080
|
$4,967,109,000 | 24.07% |
| Sera Prognostics |
No change
2,416,241
|
$4,494,208,000 | 21.78% |
| Glaukos Corporation |
No change
16,347
|
$1,230,112,000 | 5.96% |
| Dare Bioscience Inc |
No change
62,065
|
$28,662,000 | 0.14% |
| No transactions found | |||
| Showing first 500 out of 5 holdings | |||